Polypid earnings were -$29.0M for the trailing 12 months ending Dec 31, 2024, with -71.1% growth year over year. The latest PYPD earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PYPD reported annual earnings of -$29.0M, with 21.6% growth.
PYPD past earnings growth
How has PYPD's earnings growth performed historically?
On PYPD's earnings call on Invalid Date, Polypid (NASDAQ: PYPD) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total PYPD earnings for the quarter were N/A. In the same quarter last year, Polypid's earnings per share (EPS) was $30.58.
As of the last Polypid earnings report, Polypid is currently losing money. Polypid's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$29.02 million, a 21.61% increase year over year.
What was PYPD's earnings growth in the past year?
As of Polypid's earnings date in Invalid Date, Polypid's earnings has grown -71.1% year over year. This is 82.6 percentage points lower than the US Biotechnology industry earnings growth rate of 11.5%. PYPD earnings in the past year totalled -$29.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.